A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and for a triad of costimulatory molecules (PROSTVAC) in patients with metastatic castration-resistant prostate cancer. Thirty patients were trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Immunother
Autors principals: Jochems, Caroline, Tucker, Jo A., Tsang, Kwong-Yok, Madan, Ravi A., Dahut, William L., Liewehr, David J., Steinberg, Seth M., Gulley, James L., Schlom, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314199/
https://ncbi.nlm.nih.gov/pubmed/24514956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1524-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars